#FORWARDTHINKING

Patents

Application number: PCT/ES2009/000386
Gene expression profile as an endometrial receptivity marker (ERA)
07/22/2009

Application number: PCT/US2015/021495
Early detection of preeclampsia
03/21/2014

Application number: PCT/IB2015/001715
Stem cell therapy in endometrial pathologies (Asherman)
06/17/2014

Application number: 62/554,471
Methods and devices for detecting biomarkers associated with preeclampsia
09/05/2017

Application number: 62/301,825
Non-Invasive Preimplantation Genetic Analysis and Related Methods (niPGS)
03/01/2016

Application number: 62/686,621
Methods, compositions and kits for assessing endometrial transformation
06/18/2018

Simon C, Medrano JV, Pellicer A.
Direct conversion of human somatic cells to meiotic germ-like cells by genetics reprogramming.
Ref: 62/048,493. Owner: Igenomix SL.

Simon C, Garrido-Gómez T, Pellicer A.
Early detection of preeclampsia.
Ref: USSN 61/969,520. Owner: Igenomix SL

Simon C, Pellicer A, Berlanga O.
Diagnostic method for endometrial receptivity.
Ref: PCT/EP2011/050867; EP10382011.4. Owner: Igenomix SL.

Sánchez Madrid F, Yañez Mo M, Domínguez F, Simon C.
Use of CD98 as endometrial receptivity marker.
Ref: P200902193. Owner: Fundación IVI, UAMD – Universidad Autónoma de Madrid / CNIC

Pellicer A, Simon C, Gómez R.
The use of dopamine agonist to prevent ovarian hyperstimulation.
Ref: 80/138645. Owner: Fundación Instituto Valenciano de Infertilidad, sold to Ferring S.A.

Pellicer A, Simon C, Novella E.
The use of dopamine agonist to treat endometriosis.
Ref: 78/659453. Owner: Fundación Instituto Valenciano de Infertilidad, sold to Ferring S.A.

Simon C, Blesa D, Pellicer A.
Massive failure Diagnosis of the mature oocyte generation in controlled ovarian stimulation treatments.
Ref: EP12382032.6. Owner: Igenomix SL.

Simon C, Ruiz-Vela A, Aguilar-Gallardo C.
Methods for tumor treatment and adipogenesis differentiation.
Ref: US 13/251,529. Owner: Centro de Investigación Príncipe Felipe.

Krtolica A, Simon C, Foulk R.
Methods and compositions relating to embryonic stem cell lines.
Ref: US2005/046953. Owner: StemLifeLine, Inc.